These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 16967608

  • 1. [Problems of cardiovascular toxicity of coxibs and non-selective NSA].
    Forejtová S.
    Vnitr Lek; 2006; 52(7-8):677-85. PubMed ID: 16967608
    [Abstract] [Full Text] [Related]

  • 2. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.
    Solomon DH, Avorn J, Stürmer T, Glynn RJ, Mogun H, Schneeweiss S.
    Arthritis Rheum; 2006 May; 54(5):1378-89. PubMed ID: 16645966
    [Abstract] [Full Text] [Related]

  • 3. Cardiovascular complications of non-steroidal anti-inflammatory drugs.
    Fosslien E.
    Ann Clin Lab Sci; 2005 May; 35(4):347-85. PubMed ID: 16254252
    [Abstract] [Full Text] [Related]

  • 4. [Withdrawal of rofecoxib: a sign to be careful with coxibs in patients with increased cardiovascular risk].
    Bijlsma JW.
    Ned Tijdschr Geneeskd; 2004 Oct 30; 148(44):2162-4. PubMed ID: 15559407
    [Abstract] [Full Text] [Related]

  • 5. Comparative cardiovascular safety of traditional nonsteroidal anti-inflammatory drugs.
    Maillard M, Burnier M.
    Expert Opin Drug Saf; 2006 Jan 30; 5(1):83-94. PubMed ID: 16370958
    [Abstract] [Full Text] [Related]

  • 6. An evidence-based approach to prescribing nonsteroidal antiinflammatory drugs. Third Canadian Consensus Conference.
    Tannenbaum H, Bombardier C, Davis P, Russell AS, Third Canadian Consensus Conference Group.
    J Rheumatol; 2006 Jan 30; 33(1):140-57. PubMed ID: 16331802
    [Abstract] [Full Text] [Related]

  • 7. Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man.
    Dajani EZ, Islam K.
    J Physiol Pharmacol; 2008 Aug 30; 59 Suppl 2():117-33. PubMed ID: 18812633
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Is there a future for COX-2 inhibitors?].
    Yodfat Y.
    Harefuah; 2004 Nov 30; 143(11):820-4, 837. PubMed ID: 15603272
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Non-steroidal anti-inflammatory drug-induced cardiovascular adverse events: a meta-analysis.
    Gunter BR, Butler KA, Wallace RL, Smith SM, Harirforoosh S.
    J Clin Pharm Ther; 2017 Feb 30; 42(1):27-38. PubMed ID: 28019014
    [Abstract] [Full Text] [Related]

  • 14. Coxib toxicity: a likely class effect.
    Prescrire Int; 2005 Feb 30; 14(75):22. PubMed ID: 15751177
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cardiovascular thromboembolic adverse effects associated with cyclooxygenase-2 selective inhibitors and nonselective antiinflammatory drugs.
    Joshi GP, Gertler R, Fricker R.
    Anesth Analg; 2007 Dec 30; 105(6):1793-804, table of contents. PubMed ID: 18042885
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.